GlassScriptPhysician profile
Susan E Miller
NPI 1639546575
$1,159.13
in general payments reported to CMS, 2019-2025
13 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $57.82 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $196.43 | 2025 | Rezdiffra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $158.05 | 2025 | Xifaxan |
| Ardelyx, INC. | $155.61 | 2025 | Ibsrela |
| Janssen Biotech, INC. | $153.12 | 2025 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $107.82 | 2023-2025 | Entyvio, Gattex, Eohilia |
| Pfizer INC. | $78.12 | 2025 | |
| Genzyme Corporation | $74.22 | 2025 | |
| Daiichi Sankyo INC. | $56.92 | 2025 | Injectafer |
| Aimmune Therapeutics, INC. | $46.06 | 2025 | Zenpep |
| Intercept Pharmaceuticals, INC. | $40.39 | 2025 | |
| Medline Industries LP | $35.22 | 2023 | |
| Shield Therapeutics INC | $29.53 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $27.64 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.